Stay updated on Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The site footer revision label changed from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-18T03:21:05.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The record for the pembrolizumab study in anaplastic or undifferentiated thyroid cancer is displayed with its trial details, results, eligibility criteria, and study documents.
    Difference
    44%
    Check dated 2026-11-11T02:13:04.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-04T00:56:34.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    A notice about NIH’s terminology transition was added above the 403 error page, and the footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:57:36.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The site revision displayed in the footer changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T01:04:51.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The study record page now renders a 403 Forbidden error, replacing the expected study details with an access-restricted page. This indicates a permissions issue rather than a change to the study data.
    Difference
    17%
    Check dated 2026-09-23T01:09:05.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial page.